Annual long term liabilities:
$74.22M+$4.70M(+6.76%)Summary
- As of today (May 29, 2025), LGND annual total long term liabilities is $74.22 million, with the most recent change of +$4.70 million (+6.76%) on December 31, 2024.
- During the last 3 years, LGND annual long term liabilities has fallen by -$360.54 million (-82.93%).
- LGND annual long term liabilities is now -89.56% below its all-time high of $710.68 million, reached on December 31, 2019.
Performance
LGND Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$51.22M-$23.00M(-30.99%)Summary
- As of today (May 29, 2025), LGND quarterly total long term liabilities is $51.22 million, with the most recent change of -$23.00 million (-30.99%) on March 31, 2025.
- Over the past year, LGND quarterly long term liabilities has dropped by -$38.31 million (-42.79%).
- LGND quarterly long term liabilities is now -92.79% below its all-time high of $710.68 million, reached on December 31, 2019.
Performance
LGND quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
LGND Long term liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.8% | -42.8% |
| 3 y3 years | -82.9% | -81.0% |
| 5 y5 years | -89.6% | -89.8% |
LGND Long term liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.9% | +11.8% | -81.0% | at low |
| 5 y | 5-year | -89.6% | +11.8% | -90.7% | at low |
| alltime | all time | -89.6% | +2128.9% | -92.8% | +2228.1% |
LGND Long term liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $51.22M(-31.0%) |
| Dec 2024 | $74.22M(+6.8%) | $74.22M(-16.5%) |
| Sep 2024 | - | $88.92M(+22.4%) |
| Jun 2024 | - | $72.64M(-18.9%) |
| Mar 2024 | - | $89.53M(+28.8%) |
| Dec 2023 | $69.52M(+4.7%) | $69.52M(-18.8%) |
| Sep 2023 | - | $85.60M(+34.1%) |
| Jun 2023 | - | $63.83M(-3.0%) |
| Mar 2023 | - | $65.83M(-0.8%) |
| Dec 2022 | $66.37M(-84.7%) | $66.37M(-33.0%) |
| Sep 2022 | - | $99.07M(-6.6%) |
| Jun 2022 | - | $106.07M(-60.6%) |
| Mar 2022 | - | $269.41M(-38.0%) |
| Dec 2021 | $434.77M(-21.3%) | $434.77M(+2.2%) |
| Sep 2021 | - | $425.29M(+1.9%) |
| Jun 2021 | - | $417.27M(-8.0%) |
| Mar 2021 | - | $453.48M(-17.9%) |
| Dec 2020 | $552.65M(-22.2%) | $552.65M(+8.9%) |
| Sep 2020 | - | $507.32M(-2.2%) |
| Jun 2020 | - | $518.67M(+3.0%) |
| Mar 2020 | - | $503.58M(-29.1%) |
| Dec 2019 | $710.68M(+15.1%) | $710.68M(+7.5%) |
| Sep 2019 | - | $661.20M(+1.5%) |
| Jun 2019 | - | $651.40M(+0.6%) |
| Mar 2019 | - | $647.24M(+4.8%) |
| Dec 2018 | $617.64M(+4473.1%) | $617.64M(+0.8%) |
| Sep 2018 | - | $612.88M(+1.2%) |
| Jun 2018 | - | $605.62M(+5661.8%) |
| Mar 2018 | - | $10.51M(-22.2%) |
| Dec 2017 | $13.51M(+274.9%) | $13.51M(+129.3%) |
| Sep 2017 | - | $5.89M(+23.4%) |
| Jun 2017 | - | $4.78M(+20.9%) |
| Mar 2017 | - | $3.95M(+9.6%) |
| Dec 2016 | $3.60M(+8.2%) | $3.60M(-17.0%) |
| Sep 2016 | - | $4.34M(-4.3%) |
| Jun 2016 | - | $4.54M(-97.8%) |
| Mar 2016 | - | $209.12M(+6179.9%) |
| Dec 2015 | $3.33M(-98.4%) | $3.33M(-98.4%) |
| Sep 2015 | - | $213.27M(-2.1%) |
| Jun 2015 | - | $217.76M(+2.4%) |
| Mar 2015 | - | $212.67M(+0.9%) |
| Dec 2014 | $210.84M(+705.9%) | $210.84M(-0.1%) |
| Sep 2014 | - | $211.07M(+1063.5%) |
| Jun 2014 | - | $18.14M(-6.8%) |
| Mar 2014 | - | $19.46M(-25.6%) |
| Dec 2013 | $26.16M(-38.2%) | $26.16M(+7.2%) |
| Sep 2013 | - | $24.40M(-12.0%) |
| Jun 2013 | - | $27.73M(-20.2%) |
| Mar 2013 | - | $34.75M(-17.9%) |
| Dec 2012 | $42.34M(-38.4%) | $42.34M(-8.7%) |
| Sep 2012 | - | $46.39M(-16.7%) |
| Jun 2012 | - | $55.72M(-14.7%) |
| Mar 2012 | - | $65.35M(-5.0%) |
| Dec 2011 | $68.75M(+46.5%) | $68.75M(-11.4%) |
| Sep 2011 | - | $77.64M(-2.7%) |
| Jun 2011 | - | $79.79M(-5.7%) |
| Mar 2011 | - | $84.57M(+80.3%) |
| Dec 2010 | $46.92M(-45.4%) | $46.92M(-45.0%) |
| Sep 2010 | - | $85.33M(+4.9%) |
| Jun 2010 | - | $81.34M(-9.7%) |
| Mar 2010 | - | $90.04M(+4.8%) |
| Dec 2009 | $85.89M | $85.89M(+16.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2009 | - | $73.54M(-21.1%) |
| Jun 2009 | - | $93.23M(-8.1%) |
| Mar 2009 | - | $101.40M(-8.8%) |
| Dec 2008 | $111.20M(+19.3%) | $111.20M(+18.9%) |
| Sep 2008 | - | $93.54M(-3.0%) |
| Jun 2008 | - | $96.39M(-1.1%) |
| Mar 2008 | - | $97.42M(+4.5%) |
| Dec 2007 | $93.19M(-27.1%) | $93.19M(-25.7%) |
| Sep 2007 | - | $125.40M(-0.6%) |
| Jun 2007 | - | $126.19M(+10.1%) |
| Mar 2007 | - | $114.56M(-10.4%) |
| Dec 2006 | $127.89M(-32.6%) | $127.89M(-50.2%) |
| Sep 2006 | - | $256.64M(+0.2%) |
| Jun 2006 | - | $256.02M(-0.4%) |
| Mar 2006 | - | $257.02M(+35.4%) |
| Dec 2005 | $189.83M(-0.7%) | $189.83M(-0.0%) |
| Sep 2005 | - | $189.87M(-0.4%) |
| Jun 2005 | - | $190.63M(-0.2%) |
| Mar 2005 | - | $190.99M(-0.0%) |
| Dec 2004 | $191.07M(-0.4%) | $191.07M(+8.5%) |
| Sep 2004 | - | $176.17M(+0.2%) |
| Jun 2004 | - | $175.85M(-0.4%) |
| Mar 2004 | - | $176.56M(-8.0%) |
| Dec 2003 | $191.89M(+15.6%) | $191.89M(+17.1%) |
| Sep 2003 | - | $163.91M(-0.5%) |
| Jun 2003 | - | $164.72M(-0.4%) |
| Mar 2003 | - | $165.33M(-0.4%) |
| Dec 2002 | $166.06M(+15.6%) | $166.06M(+1603.0%) |
| Sep 2002 | - | $9.75M(+8.8%) |
| Jun 2002 | - | $8.96M(-6.3%) |
| Mar 2002 | - | $9.57M(-93.3%) |
| Dec 2001 | $143.62M(+2.5%) | $143.62M(-0.3%) |
| Sep 2001 | - | $144.10M(-0.5%) |
| Jun 2001 | - | $144.87M(+2.3%) |
| Mar 2001 | - | $141.60M(+1.0%) |
| Dec 2000 | $140.13M(+0.5%) | $140.13M(+14.0%) |
| Sep 2000 | - | $122.90M(+1.2%) |
| Jun 2000 | - | $121.42M(+1.3%) |
| Mar 2000 | - | $119.81M(-14.1%) |
| Dec 1999 | $139.50M(-0.7%) | $139.50M(-11.4%) |
| Sep 1999 | - | $157.50M(+18.6%) |
| Jun 1999 | - | $132.80M(+1.3%) |
| Mar 1999 | - | $131.10M(-6.7%) |
| Dec 1998 | $140.50M(+173.3%) | $140.50M(+40.9%) |
| Sep 1998 | - | $99.70M(+103.9%) |
| Jun 1998 | - | $48.90M(-6.3%) |
| Mar 1998 | - | $52.20M(+1.6%) |
| Dec 1997 | $51.40M(-4.5%) | $51.40M(+3.6%) |
| Sep 1997 | - | $49.60M(-3.9%) |
| Jun 1997 | - | $51.60M(+1.6%) |
| Mar 1997 | - | $50.80M(-5.6%) |
| Dec 1996 | $53.80M(+8.0%) | $53.80M(+12.1%) |
| Sep 1996 | - | $48.00M(-6.6%) |
| Jun 1996 | - | $51.40M(+1.6%) |
| Mar 1996 | - | $50.60M(+1.6%) |
| Dec 1995 | $49.80M(+304.9%) | $49.80M(+0.4%) |
| Sep 1995 | - | $49.60M(+313.3%) |
| Mar 1995 | - | $12.00M(-2.4%) |
| Dec 1994 | $12.30M | $12.30M(0.0%) |
| Sep 1994 | - | $12.30M(+412.5%) |
| Jun 1994 | - | $2.40M(+9.1%) |
| Mar 1994 | - | $2.20M |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual total long term liabilities?
- What is the all time high annual long term liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual long term liabilities year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly long term liabilities year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual total long term liabilities?
The current annual long term liabilities of LGND is $74.22M
What is the all time high annual long term liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual total long term liabilities is $710.68M
What is Ligand Pharmaceuticals Incorporated annual long term liabilities year-on-year change?
Over the past year, LGND annual total long term liabilities has changed by +$4.70M (+6.76%)
What is Ligand Pharmaceuticals Incorporated quarterly total long term liabilities?
The current quarterly long term liabilities of LGND is $51.22M
What is the all time high quarterly long term liabilities for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly total long term liabilities is $710.68M
What is Ligand Pharmaceuticals Incorporated quarterly long term liabilities year-on-year change?
Over the past year, LGND quarterly total long term liabilities has changed by -$38.31M (-42.79%)